Novel technologies in detection, treatment and prevention of substance use disorders

Degenhardt, 2013, Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010, Lancet, 382, 1564, 10.1016/S0140-6736(13)61530-5 Kosten, 2013, Can you vaccinate against substance abuse?, Expert Opin Biol Ther, 13, 1093, 10.1517/14712598.2013.791278 Brimijoin, 2013, Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuse, Expert Rev Vaccines, 12, 323, 10.1586/erv.13.1 Martell, 2005, Vaccine pharmacotherapy for the treatment of cocaine dependence, Biol Psychiatry, 58, 158, 10.1016/j.biopsych.2005.04.032 Orson, 2008, Substance abuse vaccines, Ann N Y Acad Sci, 1141, 257, 10.1196/annals.1441.027 Zalewska-Kaszubska, 2015, Is immunotherapy an opportunity for effective treatment of drug addiction?, Vaccine, 33, 6545, 10.1016/j.vaccine.2015.09.079 Kinsey, 2009, Anti-drug vaccines to treat substance abuse, Immunol Cell Biol, 87, 309, 10.1038/icb.2009.17 Ohia-Nwoko, 2016, Animal models and the development of vaccines to treat substance use disorders, 263, 10.1016/bs.irn.2016.02.009 Alving, 2014, Adjuvants for vaccines to drugs of abuse and addiction, Vaccine, 32, 5382, 10.1016/j.vaccine.2014.07.085 Janda, 2011, Vaccines targeting drugs of abuse: is the glass half-empty or half-full?, Nat Rev Immunol, 12, 67, 10.1038/nri3130 Kinsey, 2014, Vaccines against drugs of abuse: where are we now?, Ther Adv Vaccines, 2, 106, 10.1177/2051013614537818 Kosten, 2014, Vaccines against stimulants: cocaine and MA, Br J Clin Pharmacol, 77, 368, 10.1111/bcp.12115 Cai, 2013, Modulating cocaine vaccine potency through hapten fluorination, J Am Chem Soc, 135, 2971, 10.1021/ja400356g Cai, 2013, Probing the effects of hapten stability on cocaine vaccine immunogenicity, Mol Pharm, 10, 4176, 10.1021/mp400214w Collins, 2014, Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse, Bioconjug Chem, 25, 593, 10.1021/bc500016k Duryee, 2009, Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines, Vaccine, 27, 2981, 10.1016/j.vaccine.2009.02.105 Haile, 2015, Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine, Am J Addict, 24, 748, 10.1111/ajad.12307 Matyas, 2013, Liposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs, Vaccine, 31, 2804, 10.1016/j.vaccine.2013.04.027 Sanderson, 2003, Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant, Int Immunopharmacol, 3, 137, 10.1016/S1567-5769(02)00260-6 Laudenbach, 2015, The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse, J Immunol, 194, 5926, 10.4049/jimmunol.1500385 Pravetoni, 2014, Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats, PLoS One, 9, 10.1371/journal.pone.0096547 Taylor, 2014, Hapten-specific naive B cells are biomarkers of vaccine efficacy against drugs of abuse, J Immunol Methods, 405, 74, 10.1016/j.jim.2014.01.010 Miller, 2015, Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats, Drug Alcohol Depend, 153, 29, 10.1016/j.drugalcdep.2015.06.014 Miller, 2013, A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats, Biol Psychiatry, 73, 721, 10.1016/j.biopsych.2012.09.010 Ruedi-Bettschen, 2013, Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food, Vaccine, 31, 4596, 10.1016/j.vaccine.2013.07.038 Shen, 2013, A vaccine against methamphetamine attenuates its behavioral effects in mice, Drug Alcohol Depend, 129, 41, 10.1016/j.drugalcdep.2012.09.007 Broker, 2011, Biochemical and biological characteristics of cross-reacting material 197 CRM197, a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications, Biologicals, 39, 195, 10.1016/j.biologicals.2011.05.004 Lockner, 2015, Flagellin as Carrier and adjuvant in cocaine vaccine development, Mol Pharm, 12, 653, 10.1021/mp500520r Maoz, 2013, Adenovirus capsid-based anti-cocaine vaccine prevents cocaine from binding to the nonhuman primate CNS dopamine transporter, Neuropsychopharmacology, 38, 2170, 10.1038/npp.2013.114 Pravetoni, 2016, Biologics to treat substance use disorders: current status and new directions, Hum Vaccines Immunother, 12, 3005, 10.1080/21645515.2016.1212785 O'Hagan, 2015, New generation adjuvants--from empiricism to rational design, Vaccine, 33, B14, 10.1016/j.vaccine.2015.01.088 Lofano, 2015, Oil-in-water emulsion MF59 increases germinal center B cell differentiation and persistence in response to vaccination, J Immunol, 195, 1617, 10.4049/jimmunol.1402604 Mastelic Gavillet, 2015, MF59 mediates its B cell adjuvanticity by promoting T follicular helper cells and thus germinal center responses in adult and early life, J Immunol, 194, 4836, 10.4049/jimmunol.1402071 McCluskie, 2013, Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates, Int Immunopharmacol, 16, 50, 10.1016/j.intimp.2013.03.021 McCluskie, 2015, Anti-nicotine vaccines: comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates, Int Immunopharmacol, 29, 663, 10.1016/j.intimp.2015.09.012 Bremer, 2016, Combatting synthetic designer opioids: a conjugate vaccine ablates lethal doses of fentanyl class drugs, Angew Chem Int Ed Engl, 55, 3772, 10.1002/anie.201511654 Bremer, 2014, Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy, Mol Pharm, 11, 1075, 10.1021/mp400631w Chen, 2012, High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants, Vaccine, 31, 159, 10.1016/j.vaccine.2012.10.069 Friedman, 2006, Addictive drugs and their relationship with infectious diseases, FEMS Immunol Med Microbiol, 47, 330, 10.1111/j.1574-695X.2006.00097.x Karila, 2008, New treatments for cocaine dependence: a focused review, Int J Neuropsychopharmacol, 11, 425, 10.1017/S1461145707008097 Preti, 2007, New developments in the pharmacotherapy of cocaine abuse, Addict Biol, 12, 133, 10.1111/j.1369-1600.2007.00061.x Carrera, 2001, A second-generation vaccine protects against the psychoactive effects of cocaine, Proc Natl Acad Sci USA, 98, 1988, 10.1073/pnas.98.4.1988 Fox, 1996, Efficacy of a therapeutic cocaine vaccine in rodent models, Nat Med, 2, 1129, 10.1038/nm1096-1129 Jenkins, 2002, Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration, J Anal Toxicol, 26, 382, 10.1093/jat/26.7.382 Danger, 2006, Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues, J Immunol Methods, 309, 1, 10.1016/j.jim.2005.10.017 Peterson, 2008, Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine, J Pharmacol Exp Ther, 325, 124, 10.1124/jpet.107.134395 Wille, 2010, Evaluation of on-site oral fluid screening using drugwipe-5(+), RapidSTAT and drug test 5000 for the detection of drugs of abuse in drivers, Forensic Sci Int, 198, 2, 10.1016/j.forsciint.2009.10.012 Braithwaite, 1995, Screening for drugs of abuse. I: opiates, amphetamines and cocaine, Ann Clin Biochem, 32, 123, 10.1177/000456329503200203 Niedbala, 2001, Detection of analytes by immunoassay using up-converting phosphor technology, Anal Biochem, 293, 22, 10.1006/abio.2001.5105 Fitzpatrick, 2000, Applications and recent developments in the use of antibodies for analysis, Anal Lett, 33, 2563, 10.1080/00032710008543210 Roushani, 2015, A novel ultrasensitive aptasensor based on silver nanoparticles measured via enhanced voltammetric response of electrochemical reduction of riboflavin as redox probe for cocaine detection, Sens Actuators B Chem, 207, 764, 10.1016/j.snb.2014.10.131 Demir, 2016, Polypeptide with electroactive endgroups as sensing platform for the abused drug 'methamphetamine' by bioelectrochemical method, Talanta, 161, 789, 10.1016/j.talanta.2016.09.042 Bozokalfa, 2016, Polypeptide functional surface for the aptamer immobilization: electrochemical cocaine biosensing, Anal Chem, 88, 4161, 10.1021/acs.analchem.6b00760 Guler, 2017, An aptamer folding-based sensory platform decorated with nanoparticles for simple cocaine testing, Drug Test Anal, 9, 578, 10.1002/dta.1992 Arslan, 2017, Double fluorescence assay via a β-cyclodextrin containing conjugated polymer as a biomimetic material for cocaine sensing, Polym Chem, 8, 3333, 10.1039/C7PY00420F Concheiro, 2007, Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing, Forensic Sci Int, 170, 156, 10.1016/j.forsciint.2007.03.034 Kintz, 2009, Evaluation of the Cozart DDSV test for cannabis in oral fluid, Ther Drug Monit, 31, 131, 10.1097/FTD.0b013e3181947916 Lin, 2018, Urine specimen validity test for drug abuse testing in workplace and court settings, J Food Drug Anal, 26, 380, 10.1016/j.jfda.2017.01.001 Hopson, 2015, The effectiveness of electronic approaches to substance abuse prevention for adolescents, J Evid Inf Soc Work, 12, 310, 10.1080/15433714.2013.857178 Michie, 2004, Interventions to change health behaviours: evidence-based or evidence-inspired?, Psychol Health, 19, 29, 10.1080/0887044031000141199 Marsch, 2012, Leveraging technology to enhance addiction treatment and recovery, J Addict Dis, 31, 313, 10.1080/10550887.2012.694606 Copeland, 2011, Application of technology in the prevention and treatment of substance use disorders and related problems: opportunities and challenges, Subst Use Misuse, 46, 112, 10.3109/10826084.2011.521423 Carra, 2016, Impact of a mobile e-health intervention on binge drinking in young people: the digital-alcohol risk alertness notifying network for adolescents and young adults project, J Adolesc Health Off Publ Soc Adolesc Med, 58, 520, 10.1016/j.jadohealth.2016.01.008 Whittaker, 2016, Mobile phone-based interventions for smoking cessation, Cochrane Database Syst Rev, 4 Marsch, 2016, Technology-based interventions for preventing and treating substance use among youth, Child Adolesc Psychiatr Clin N Am, 25, 755, 10.1016/j.chc.2016.06.005 Barak, 2008, A comprehensive review and a meta-analysis of the effectiveness of internet-based psychotherapeutic interventions, J Technol Hum Serv, 26, 109, 10.1080/15228830802094429 Lovejoy, 2009, Advancing the practice of online psychotherapy: an application of Rogers' diffusion of innovations theory, Psychotherapy (Chicago, Ill.), 46, 112, 10.1037/a0015153 Barak, 2009, Defining internet-supported therapeutic interventions, Ann Behav Med: Publ Soc Behav Med, 38, 4, 10.1007/s12160-009-9130-7 King, 2012, Clinical interventions for technology-based problems: excessive internet and video game use, J Cogn Psychother, 26, 43, 10.1891/0889-8391.26.1.43 Mounteney, 2016, The internet and drug markets: shining a light on these complex and dynamic systems, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Insights, 21, 13 Sanavio, 2015, On the slow diffusion of point-of-care systems in therapeutic drug monitoring, Front Bioeng Biotechnol, 3, 20 Kosten, 2002, Human therapeutic cocaine vaccine: safety and immunogenicity, Vaccine, 20, 1196, 10.1016/S0264-410X(01)00425-X Martell, 2009, Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial, Arch Gen Psychiatry, 66, 1116, 10.1001/archgenpsychiatry.2009.128 Haney, 2010, Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans, Biol Psychiatry, 67, 59, 10.1016/j.biopsych.2009.08.031 Carrera, 1995, Suppression of psychoactive effects of cocaine by active immunization, Nature, 378, 727, 10.1038/378727a0 Byrnes-Blake, 2001, Generation of anti-(+)methamphetamine antibodies is not impeded by (+)methamphetamine administration during active immunization of rats, Int Immunopharmacol, 1, 329, 10.1016/S1567-5769(00)00019-9 Moreno, 2011, Impact of distinct chemical structures for the development of a methamphetamine vaccine, J Am Chem Soc, 133, 6587, 10.1021/ja108807j